Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer.

Xiaolong Jia,Dongxu Zhang,Cheng Zhou,Zejun Yan,Zhaohui Jiang,Liping Xie,Junhui Jiang

Frontiers in oncology（2023）

引用 0|浏览11

暂无评分

摘要

This study comprehensively investigated the immunological effects of Eph receptor/EFN ligand family genes pan-cancer, and specially identified the immunosuppressive role of EPHB6 in BLCA. Furthermore, EPHB6 may predict the molecular subtype and prognosis of BLCA, and serve as a novel therapeutic target to improve the sensitivity of immunotherapy.

查看译文

关键词

bladder anti-cancer,immunotherapy response,cold immune microenvironment,immunity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要